Brief: Shanghai Haohai Biological Technology to buy 70% of share capital in a uk company
April 13 (Reuters) - Shanghai Haohai Biological
Technology Co Ltd 6826.HK :
* Haohai healthcare holdings (bvi) co., ltd., and sellers
entered into a share purchase agreement
* Simon david wyatt, robert john mcgregor, robert edward
lewis and john alexander mcgregor, collectively as "sellers"
* Deal for a consideration of approximately hkd241.1 million
* Sellers agreed to sell 70% of share capital in a uk
company to haohai healthcare holdings (bvi)
Source text for Eikon: ID:nHKS4nW2wy
Further company coverage: 6826.HK
((Bangalore.newsroom@thomsonreuters.com ;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.